More May, 2004 pharmacogenomics journal articles.- Medication selection by genotype: How genetics is changing drug prescribing and efficacy.
by Prows CA, Prows DR.
Journal: Am J Nurs. 104(5):60-70; quiz 71
- DNA microarrays as a tool in toxicogenomics.
by de Longueville F, Bertholet V, Remacle J.
Journal: Comb Chem High Throughput Screen. 7(3):207-11
- Pharmacogenomics and IBD: TPMT and thiopurines.
by Sandborn WJ.
Journal: Inflamm Bowel Dis. 10 Suppl 1:S35-7
- The future of pharmacy education: back to which basics?
by Sansgiry SS.
Journal: Pharmacotherapy. 24(5):688-9; discussion 691-3
- Monitoring plasma concentrations to individualize treatment with clomiphene citrate.
by Rostami-Hodjegan A, Lennard MS, Tucker GT, Ledger WL.
Journal: Fertil Steril. 81(5):1187-93
- [Pharmacogenetics--new perspectives in the treatment of cardiovascular diseases]
by Dzida G.
Journal: Kardiol Pol. 60(3):304-8
- Dihydropyrimidine dehydrogenase pharmacogenetics in the Taiwanese population.
by Hsiao HH, Yang MY, Chang JG, Liu YC, Liu TC, Chang CS, Chen TP, Lin SF.
Journal: Cancer Chemother Pharmacol. 53(5):445-51
- Effects of mefloquine usage on genetic polymorphism of Plasmodium falciparum in Thai-Myanmarese border.
by Matsuo T, Shirakawa T, Singhasivanon P, Looareesuwan S, Kawabata M.
Journal: Kobe J Med Sci. 49(5-6):143-51
- Variation in vaccine response in normal populations.
by Ovsyannikova IG, Jacobson RM, Poland GA.
Journal: Pharmacogenomics. 5(4):417-27
- The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation.
by MacPhee IA, Fredericks S, Tai T, Syrris P, Carter ND, Johnston A, Goldberg L, Holt DW.
Journal: Am J Transplant. 4(6):914-9
- Clinical relevance of advances in genetics and pharmacogenetics of IBD.
by Ahmad T, Tamboli CP, Jewell D, Colombel JF.
Journal: Gastroenterology. 126(6):1533-49
- Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned?
by Huang SM, Lesko LJ.
Journal: J Clin Pharmacol. 44(6):559-69
- Personalized medicine.
by Thrall JH.
Journal: Radiology. 231(3):613-6
- Oral GPIIb/IIIa antagonists: what went wrong?
by Cox D.
Journal: Curr Pharm Des. 10(14):1587-96
- Use of pharmacogenetics to guide warfarin therapy.
by Voora D, McLeod HL, Eby C, Gage BF.
Journal: Drugs Today (Barc). 40(3):247-57
- Communication of medical product risk: how effective is effective enough?
by Goldman SA.
Journal: Drug Saf. 27(8):519-34
- Neonatal exposure to drugs in breast milk.
by McNamara PJ, Abbassi M.
Journal: Pharm Res. 21(4):555-66
- The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes.
by Sesti G, Marini MA, Cardellini M, Sciacqua A, Frontoni S, Andreozzi F, Irace C, Lauro D, Gnasso A, Federici M, Perticone F, Lauro R.
Journal: Diabetes Care. 27(6):1394-8
- Pharmacogenomics and transplantation: where are we?
by Frassetto LA, Benet LZ.
Journal: Am J Transplant. 4(6):843
More pharmacogenomics journal articles ... |